Poland· PL-100409335

Argosulfan

A sulfathiazole product containing sulfathiazolum argentum, registered in Poland by Pharmapoint SA.

ATC D06BA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedArgosulfanATCD06BA02REGISTER NO.PL-100409335PACKS LISTED1CHECKEDAugust 23, 2026

The record

At a glance

URPL (Poland)
Active substance
Sulfathiazolum argentum
Manufacturer
Pharmapoint SA
Country
Poland (PL)
ATC code
D06BA02
ATC class
Sulfathiazole
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
August 23, 2026

Packs & prices · 1

  • gtin
    05909991382148

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dbab252e-9323-4278-89b5-824c77e60cb6
GET /v1/drugs/dbab252e-9323-4278-89b5-824c77e60cb6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "20 mg/g",
  "packaging": "05909991382148 ¦ Rp ¦ 129367\n1 tuba 40 g",
  "substance": "Sulfathiazolum argentum 20 mg/g",
  "common_name": "Sulfathiazolum argentum",
  "pl_product_id": "100409335",
  "pozwolenie_nr": "250/18",
  "auth_procedure": "IR",
  "authorisation_validity": "2023-08-27"
}

See everything about sulfathiazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.